Navigation Links
Telik Announces Fourth Quarter And 2012 Year End Financial Results And 2013 Financial Guidance
Date:3/15/2013

PALO ALTO, Calif., March 15, 2013 /PRNewswire/ -- Telik, Inc. (Nasdaq: TELK) reported a net loss of $1.8 million, or $0.66 per share, for the three months ended December 31, 2012, compared with a net loss of $2.5 million, or $1.38 per share, for the comparable period in 2011.  For the year ended December 31, 2012, net loss was $8.0 million, or $3.64 per share, compared with a net loss of $12.0 million, or $6.69 per share, for the year ended December 31, 2011.  Net loss per share for both periods were adjusted for the 1-for-30 reverse split of the company's common stock effected on March 30, 2012.

For the quarter ended December 31, 2012, total operating costs and expenses were $1.8 million compared with $2.5 million in the fourth quarter of 2011, representing a reduction of approximately 29%, primarily due to lower headcount, reduced clinical trial expenses, and lower corporate and stock-based compensation expenses.

Operating costs and expenses for the year ended December 31, 2012 were $8.0 million, compared with $12.1 million for the same period in 2011. Operating costs and expenses in 2012 included approximately $0.7 million in stock-based compensation expense compared to $1.6 million in 2011. The reduction in operating costs and expenses of approximately 34% in the year ended December 31, 2012, compared with 2011, were primarily due to lower headcount, reduced clinical trial expenses, and lower corporate and stock-based compensation expenses.

At December 31, 2012, Telik had $5.0 million in cash, cash equivalents, restricted cash and investments, compared with $11.7 million at December 31, 2011.

2012 Highlights

Regulatory:

  • Telik's product candidate, ezatiostat HCL (Telintra), was granted orphan drug designation by the US Food and Drug Administration (FDA) for the treatment of myelodysplastic synd
    '/>"/>

    • SOURCE Telik, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Telik Announces Third Quarter 2012 Financial Results
    2. Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Teli
    3. ULURU Inc. Announces Closing Of $440,000 Private Placement
    4. Cardica Announces Proposed Public Offering of Common Stock
    5. PAREXEL International Provides Update On Share Repurchase Program, Announces A New $50 Million Accelerated Share Repurchase Agreement And A New $50 Million 10b5-1 Trading Plan
    6. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Spectrum Pharmaceuticals, Inc.
    7. Simbionix Announces License Agreement for Surgical Videos
    8. BioTrends Announces the Continuation of a Syndicated Report Series: TreatmentTrends: CKD Stages 1-5ND
    9. Keryx Biopharmaceuticals Announces Appointment of Amit Sharma, M.D. as Vice President, Medical Affairs
    10. Imprimis Pharmaceuticals Announces Underwriter Exercise of Over-Allotment Option
    11. PDI, Inc. Announces $17 Million Multi-Year Sales Contract
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/23/2013)... May 23, 2013  Hadasit Bio-Holdings Ltd. (TASE: HDST, ... companies, based on intellectual property developed and owned ... ,s foremost medical research center, today announced that ... significant funding from the Israeli Ministry of Industry ... to support product development and advance clinical trials. ...
    (Date:5/23/2013)... SANTA MONICA, Calif. , May 23, 2013 /PRNewswire-USNewswire/ ... of a program that would have required them to ... announced today by Consumer Watchdog and Whatley Kallas LLC.  ... San Diego Superior Court, alleged that Blue Cross,s mandatory ... HIV/AIDS patients, threatening their health and privacy. ...
    (Date:5/23/2013)... , May 23, 2013  Hologic, Inc. ... ), a leading developer, manufacturer and supplier of ... with an emphasis on serving the healthcare needs ... observational study in a U.S. clinical practice comparing ... (breast tomosynthesis) with conventional 2D mammography alone showed ...
    Breaking Medicine Technology:Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4
    (Date:5/24/2013)... 24 (HealthDay News) -- New research suggests a ... people with insomnia. Every additional hour someone ... percent drop in the likelihood of moderate or ... the University of Pennsylvania. "We were ... sleep duration and suicide risk," study author, Linden ...
    (Date:5/24/2013)... OR (PRWEB) May 24, 2013 ... Sustainable Cards, major competitors in sustainable card material, ... of using forest materials as a sustainable gift ... is to identify industry challenges and increase education ... card programs to support the reduction of carbon ...
    (Date:5/24/2013)... New York, New York (PRWEB) May 24, 2013 ... naturally white teeth. It is not uncommon for the majority ... natural teeth. Whether it is due to a coffee addiction ... this is why whitening procedures are so popular. ... of a new and very effective whitening system: Venus White ...
    (Date:5/24/2013)... City, Utah (PRWEB) May 24, 2013 ... , with exciting new enhancements for instructors and students. ... stay more focused through personalize learning plan templates, targeted ... AnatomyOne release provides 500 new assessment questions, 5,000 searchable ... review notes. , AnatomyOne 2.0 is the ...
    (Date:5/24/2013)... central to the development of infantile myofibromatosis (IM)a disorder ... soft tissuemay provide new therapeutic targets, according to researchers ... The findings, published in the American Journal of ... for this debilitating disease, for which the only current ... , IM is an inheritied disorder that develops in ...
    Breaking Medicine News(10 mins):Health News:Sleep Duration Linked to Suicidal Thoughts in People With Insomnia 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 3Health News:Herald Square Dental Introduces New In-office Whitening System: Venus White Max 2Health News:Amirsys AnatomyOne 2.0 Delivers Personalized Learning Plans 2Health News:Researchers identify first drug targets in childhood genetic tumor disorder 2
    ... New research shows that at least 10 percent of genes ... copies of DNA sequences they contain—a finding that alters current// ... percent similar in content and identity. ,This discovery ... Institute (HHMI) international research scholar Stephen W. Scherer, and colleagues, ...
    ... that can cause deadly infections in humans and ... “eating” tumors from the inside out. Now, two ... Center have demonstrated that, combined with specially-packaged anti-cancer ... have dramatically improved. ,In mouse experiments ...
    ... rate of diabetic foot amputations is high in India, which ... can be considerably reduced with proper foot care. // ... but special footwear is required for patients who suffer foot ... Hospital has tied up with the Harvard Medical School, Boston, ...
    ... that conducted a study on schizophrenic patients has come up ... to the older anti-psychotic drugs. // ,The study ... in drugs as the treatment they were getting was ineffective. ... drugs and others on new. Experienced doctors decided which type ...
    ... has caused Japan to temporarily suspend the import of ... chickens have died as a result of the outbreak. ... been sought from South Korea. "As a precaution, we ... Chief Cabinet Secretary Yasuhisa Shiozaki of Japan said. ...
    ... as heroin and crack impacts the economic health of England and ... ,These costs were delineated as cost of frauds, thefts, bills of ... figures have shown that illegal drugs are easier on the pocket, ... instance it was found that brown heroin was cheaper by 47% ...
    Cached Medicine News:Health News:Genetic Variation: We're More Different than We Thought 2Health News:Genetic Variation: We're More Different than We Thought 3Health News:Germ - Chemo Combo Fights Cancer 2Health News:Germ - Chemo Combo Fights Cancer 3Health News:Old Anti-psychotic Drugs Are Equally Good 2
    ... multichannel has the same innovative ... model. The same universal handle ... five single channel tip cone ... recharge and storage stand with ...
    ... pro Electronic Pipette is ideal for all ... easy-to-follow display, ergonomically-placed operating buttons, and various ... pipetting and diluting make this a lab ... of a manual pipette without any adverse ...
    ... Pick one of our pipettors up and ... and ejector positionsright where they should beeven if ... designed to help avoid repetitive stress injuries caused ... The Palm Of Your Hand Start dispensing ...
    ... Comfort Pick one of our pipettors up ... trigger and ejector positionsright where they should beeven ... ergonomically designed to help avoid repetitive stress injuries ... In The Palm Of Your Hand Start ...
    Medicine Products: